Endo International (NASDAQ:ENDP) Stock Tanked 62% Last Week: Here is Why

May 23, 2022

Specialty pharmaceutical company Endo International (NASDAQ:ENDP) saw its stock go through a collapse last week as it slumped by as much as 62% for the week amidst a heavy selloff. Trading Data On Friday, ENDP stock slid 19.50% to $0.4650 with more than 26.84 million shares, compared to its average volume of 7.08 million shares. The stock moved within a range of $0.4201 – 0.6200 after opening trade at $0.5868….

Read More >>

Inovio Pharmaceutical (NASDAQ:INO) Stock Continues to Fall: Down 65% YTD

May 23, 2022

There was a time when many vaccine-related stocks had managed to emerge as major gainers in light of the coronavirus pandemic and the race for discovering a vaccine. However, things have cooled down somewhat in recent times and a case in point is the Inovio Pharmaceutical (NASDAQ:INO) stock. Trading Data On Friday, INO stock decreased 4.57% to $1.88 with more than 7.40 million shares, compared to its average volume of…

Read More >>

Indaptus Therapeutics Inc (NASDAQ:INDP) Announces FDA Clearance: Stock Falls

May 23, 2022

It was a tough day in the markets for investors in the company Indaptus Therapeutics Inc (NASDAQ:INDP) as its stock suffered from a selloff and ended the day with a decline of as much as 8%. Trading Data On Friday, INDP stock fell 7.41% to $2.75 with more than 1.23 million shares, compared to its average volume of 479k shares. The stock moved within a range of $2.3000 – 2.8500…

Read More >>

Tencent Music Entertainment Group (NYSE:TME) Stock In Focus After Recent News

May 23, 2022

While it is true that the Tencent Music Entertainment Group (NYSE:TME) stock was trading within a range on Friday, it should also be noted that the company did make a major announcement and that hence, it may be a good idea to take a bit of an interest in the stock. Trading Data On Friday, TME stock moved up 0.25% to $4.07 with more than 18.05 million shares traded, compared…

Read More >>

Camber Energy (NYSEAMERICAN:CEI) Stock reacts To Positive Delayed Earnings Report

May 23, 2022

Last Friday, it was the time for the Camber Energy (NYSEAMERICAN:CEI) stock to shine as the company finally announced its financial results following a significant delay. That came as a major bullish trigger for the stock and it ended the week with gains of as much as 9%. Trading Data On Friday, CEI stock gained 3.16% to $0.78 with more than 43.14 million shares, compared to its average volume of…

Read More >>

Vinco Ventures (NASDAQ:BBIG) Stock Gains Ahead of Cryptyde Record Date

May 23, 2022

The previous week was a significant one for Vinco Ventures (NASDAQ:BBIG) as its stock experienced significant attention from investors and ended up with gains of as much as 10% for the week. It would likely remain on the radars of investors this week and hence, it may be a good time to take a look at the reason behind the rally. Trading Data On Friday, BBIG stock increased 4% to…

Read More >>

TherapeuticsMD Inc (NASDAQ:TXMD) Stock Sees Short-Squeeze Rally

May 23, 2022

This morning the TherapeuticsMD Inc (NASDAQ: TXMD) stock is almost certain to come into focus among investors considering the fact that this past Friday it had clocked gains of as much as 36%. The rally in the stock on Friday came about after the company made a major announcement with regards to its product ANNOVERA. Trading Data      On Friday, TXMD stock surged 36.56% to $3.10 with more than 22.13 million…

Read More >>

NioCorp Developments Ltd (OTCMKTS:NIOBF) stock Soars After Updates On Elk Creek Project

May 23, 2022

Those who are currently looking into some of the stocks which may have clocked significant gains on Friday could consider tracking the NioCorp Developments Ltd (OTCMKTS:NIOBF) stock. It was one of the biggest movers on Friday amidst heavy interest and ended up with gains of as much as 38% as a consequence. Trading Data On Friday, NIOBF stock soared 37.80% to $0.9646 with more than 1.64 million shares traded, compared…

Read More >>

Immix Biopharma Inc. (NASDAQ:IMMX) Stock Soars IMX-110 Demonstrated Improved Survival

May 23, 2022

Immix Biopharma Inc. (NASDAQ: IMMX) was up 30% after the biopharmaceutical firm pioneering Tissue-Specific Therapeutics targeting immune-dysregulated and oncology diseases announced positive preliminary trial data showing that after one treatment cycle, its lead candidate IMX-110 had 75% survival compared to 0% survival for FDA-approved drug Trabectedin that is sold as YONDELIS. Trading Data On Friday, IMMX stock gained 30.06% to $2.12 with more than 111.65 million shares, compared to its…

Read More >>